Paul Edward Kelly's Net Worth
Paul Edward Kelly's net worth is estimated to be at least $7,654,974.00 as of 06/27/2025. CoreStreet's estimation of Paul Edward Kelly's net worth is based on their sale of stock and current holding of stock.
Paul Edward Kelly is COO at Relmada Therapeutics Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 200,000 units of RLMD stock on 05/16/2025. Their biggest sale was on 01/22/2021 when they sold 2,100 units of Relmada Therapeutics Inc stock for $6,388,263.00. They typically trade 2 times per year.
Total value of insider buys:
- $527,050.00
Total value of insider sells:
- $7,127,924.00
Most recent insider trade:
- May 16, 2025
Paul Edward Kelly's Insider Trading History
| Relmada Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 16, 2025 | COO | 200,000 | $0.43 | Buy | $86,000.00 |
April 4, 2022 | Director | 10,000 | $30.04 | Sell | $300,400.00 |
March 9, 2021 | Director | 5,000 | $35.71 | Sell | $178,550.00 |
Feb. 8, 2021 | Director | 1,500 | $35.04 | Sell | $52,560.00 |
Jan. 27, 2021 | Director | 5,000 | $32.46 | Sell | $162,300.00 |
Jan. 25, 2021 | Director | 1,300 | $35.27 | Sell | $45,851.00 |
Jan. 22, 2021 | Director | 2,100 | $3,042.03 | Sell | $6,388,263.00 |
Oct. 18, 2019 | Director | 5,000 | $30.00 | Buy | $150,000.00 |
May 14, 2019 | Director | 100,000 | $1.50 | Buy | $150,000.00 |
Dec. 11, 2018 | Director | 5,000 | $1.21 | Buy | $6,050.00 |
Oct. 12, 2018 | Director | 150,000 | $0.90 | Buy | $135,000.00 |